We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Invasive Ductal Carcinoma of the Breast in a Transgender Man: A Case Report.
- Authors
Heng, Yujing J.; Zhang, Kevin J.; Valero, Monica G.; Baker, Gabrielle M.; Fein-Zachary, Valerie J.; Irwig, Michael S.; Wulf, Gerburg M.
- Abstract
There is limited literature about breast cancer in the transgender population. Very little is known about how gender-affirming hormone therapy affects their breast cancer risk. On the other end, for those diagnosed with breast cancer, there are no clinical guidelines to manage their breast cancer, specifically, how to manage their gender-affirming hormone therapy during breast cancer treatment. Here, we report a 52-year-old transman diagnosed with a grade 2 invasive ductal carcinoma (ER+/PR+/HER2−), and ductal carcinoma in situ (DCIS) of intermediate grade. We discussed his risk factors as well as treatment options.
- Subjects
DUCTAL carcinoma; TRANS men; LOBULAR carcinoma; CARCINOMA in situ; BREAST cancer; HORMONE therapy
- Publication
Case Reports in Oncology, 2023, Vol 16, Issue 1, p811
- ISSN
1662-6575
- Publication type
Article
- DOI
10.1159/000529859